patients with stage iv or recurrent adenocarcinoma of the lung
Showing 1 - 1 of 1
Patients With Stage IV or Recurrent Adenocarcinoma of the Lung Trial (Abraxane, Gemcitabine)
Completed
- Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
- (no location specified)
Sep 28, 2021